Hims & Hers Health (HIMS) drops 15% premarket after halting compounded Wegovy pill sales amid FDA scrutiny and Novo Nordisk pressure. Samsung (SSNLF) surges on imminent HBM4 chip mass production, reportedly shipping to Nvidia for next-gen AI accelerators.









